Regenosine

New Jersey, Trinidad and Tobago

Regenosine is developing a disease-modifying regenerative therapy for osteoarthritis.

$25K raised

Feb 2023

Grant

Top Investors

30,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Regenosine raised?

Regenosine has raised $25K in total funding. The most recent round was Grant. The last funding was announced in February 2023.

Who are Regenosine's investors?

Regenosine's investors include Creative Destruction Lab, NJEDA, SeedFolio, NIAMS.

Where is Regenosine headquartered?

Regenosine is headquartered in New Jersey, Trinidad and Tobago.

What does Regenosine do?

Regenosine is developing a disease-modifying regenerative therapy for osteoarthritis.

What stage is Regenosine at?

Regenosine is at the Grant stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated February 16, 2023.

MLA

"Regenosine — Funding & Investors." VCBacked, February 16, 2023, https://www.vcbacked.co/company/regenosine. Accessed July 4, 2026.

APA

VCBacked. (2023). Regenosine — Funding & Investors. Retrieved July 4, 2026, from https://www.vcbacked.co/company/regenosine

Wikipedia (cite web)

{{cite web |title=Regenosine — Funding & Investors |url=https://www.vcbacked.co/company/regenosine |website=VCBacked |access-date=July 4, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated February 16, 2023.